Structure of plantaricin locus of Lactobacillus plantarum 8P-A3

Beneficial Microbes

Volumn 2, Issue 4, 2011, Pages 255-261

  Tsapieva, A ^a   Duplik, N ^a   Suvorov, A ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Russian Federation)

Author keywords

Antagonistic activity; Bacteriocin EF; Bacteriocin NC8; Streptococci

Indexed keywords

BACTERIOCIN; PROBIOTIC AGENT; BACTERIAL DNA;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL GENOME; BACTERIAL STRAIN; CONTROLLED STUDY; GENE LOCUS; GENE SEQUENCE; GENE STRUCTURE; GENOME ANALYSIS; LACTOBACILLUS PLANTARUM; NONHUMAN; NUCLEOTIDE SEQUENCE; PLANTARICIN GENE; REGULON; BIOSYNTHESIS; CHEMISTRY; DNA SEQUENCE; GENE ORDER; GENETICS; METABOLISM; MOLECULAR GENETICS; MULTIGENE FAMILY;

BACTERIOCINS; BIOSYNTHETIC PATHWAYS; DNA, BACTERIAL; GENE ORDER; GENES, BACTERIAL; LACTOBACILLUS PLANTARUM; MOLECULAR SEQUENCE DATA; MULTIGENE FAMILY; SEQUENCE ANALYSIS, DNA;

EID: 84858592725     PISSN: 18762883     EISSN: 18762891     Source Type: Journal    
DOI: 10.3920/BM2011.0030     Document Type: Article

References (28)

1. Anderssen, E.L., Diep, D.B., Nes, I.F., Eijsink, V.G.H. and Nissen-Meyer, J., 1998. Antagonistic activity of Lactobacillus plantarum C11: two new two-peptide bacteriocins, plantaricins EF and JK, and the induction factor plantaricin A. Applied and Environmental Microbiology 64: 2269-2272.
2. Azcarate-Peril, M.A., Sikes, M. and Bruno-Barcena, J.M., 2011. The intestinal microbiota, gastrointestinal environment and colorectal cancer: a putative role for probiotics in prevention of colorectal cancer? American Journal of Physiology -Gastrointestinal and Liver Physiology 301: G401-G424.
3. Borriello, S.P., Hammes, W.P., Holzapfel, W., Marteau, P., Schrezenmeir, J., Vaara, M. and Valtonen, V., 2003. Safety of probiotics that contain lactobacilli or bifidobacteria. Clinical Infectious Diseases 36: 775-780.
4. Cassani, E., Privitera, G., Pezzoli, G., Pusani, C., Madio, C., Iorio, L. and Barichella, M., 2011. Use of probiotics for the treatment of constipation in Parkinson's disease patients. Minerva Gastroenterologica e Dietologica 57: 117-121.
5. Diep, D.B., Straume, D., Kjos, M., Torres, C. and Nes, I.F., 2009. An overview of the mosaic bacteriocin pln loci from Lactobacillus plantarum. Peptides 30: 1562-1574.
6. Ermolenko, E.I., Isakov, V.A., Zhdan-Pushkina, S.K. and Tets, V.V., 2004. Quantitative characterization of antagonistic activity of lactobacilli. Zhurnal Mikrobiologii, Epidemiologii, i Immunobiologii 5: 94-98.
7. Feclisova, L.V., Tselipanova, E.E. and Galkina, L.A., 2010. Results of the multicentral study on application of combined probiotic containing bifido and lactobacteria in patients with respiratory infectious diseases. Journal of Children Infections 3: 7-11.
8. Food and Agriculture Organization of the United Nations/World Health Organization (FAO/WHO), 2001. Joint FAO/WHO expert consultation on health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria, 1-4 October 2001, Córdoba, Argentina. Available at: http://www.who.int/foodsafety/publications/fs_management/probiotics/en/.
9. Gong, H.S., Meng, X.C. and Wang, H., 2010. Mode of action of plantaricin MG, a bacteriocin active against Salmonella typhimurium. Journal of Basic Microbiology 50 Suppl. 1: S37-S45.
10. Hickson, M., 2011. Probiotics in the prevention of antibiotic-associated diarrhoea and Clostridium difficile infection. Therapeutic Advances in Gastroenterology 4: 185-197.
11. Kolpakov, A.I., Iunusov, D.V., Garusov, A.V. and Kupriianova-Ashina, F.G., 1998. Use of exogenous ribonuclease for improvement of Lactobacillus biological properties. Antibiotics and Chemotherapy 43: 5-8.
12. Molokhova, E.I. and Tarasevits, V.N., 2000. Therapeutic probiotic medicines on the Russian pharmaceutical market. Pharmacia Journal 3: 55-58.
13. Molokhova, Y.I., Sorokina, Y.V., Chistokhina, L.P. and Neschislyaev, V.A., 2006. The development of a probiotic drug based upon ultrafiltrate of a cultural lactobacterial fluid. Bulletin of Siberian Medicine Appendix 2: 111-112.
14. Navarro, L., Rojo-Bezares, B., Sáenz, Y., Díez, L., Zarazaga, M., Ruiz-Larrea, F. and Torres, C., 2008. Comparative study of the pln locus of the quorum-sensing regulated bacteriocin-producing L. plantarum J51 strain. International Journal of Food Microbiology 128: 390-394.
15. Neschisliaev, V.A., 1998. Probiotics: retrospective view, problems and achievements of the scientific-industrial practice at the Scientific-Industrial Complex 'Biomed'. Zhurnal Mikrobiologii, Epidemiologii, i Immunobiologii 2: 100-102.
16. Neschisliaev, V.A., Vdovina, G.P., Puchnin, V.S., Chugunova, N.N., Molokhova, E.I. and Raguzina, S.V., 1998. Development of methods for the stabilization of biomass in the preparation of medicinal forms of lactobacterin. Zhurnal Mikrobiologii, Epidemiologii, i Immunobiologii 2: 102-104.
17. Reid, G., Burton, J. and Devillard, E., 2004. The rationale for probiotics in female urogenital healthcare. Medscape Journal of Medicine 6: 49.
18. Rojo-Bezares, B., Sáenz, Y., Navarro, L., Jiménez-Díaz, R., Zarazaga, M., Ruiz-Larrea, F. and Torres, C., 2008. Characterization of a new organization of the plantaricin locus in the inducible bacteriocinproducing Lactobacillus plantarum J23 of grape must origin. Archives of Microbiology 189: 491-499.
19. Sáenz, Y., Rojo-Bezares, B., Navarro, L., Díez, L., Somalo, S., Zarazaga, M., Ruiz-Larrea, F. and Torres, C., 2009. Genetic diversity of the pln locus among oenological Lactobacillus plantarum strains. International Journal of Food Microbiology 134: 176-183.
20. Soliman, W., Wang, L., Bhattacharjee, S. and Kaur, K., 2011. Structureactivity relationships of an antimicrobial peptide plantaricin S from two-peptide class IIb bacteriocins. Journal of Medicinal Chemistry 54: 2399-2408.
21. Sorokulova, I.B., Khil'ko, T.V. and Osadchaia, A.I., 2003. Development of nutrient medium for the cultivation of Lactobacillus plantarum 8P-A3. Mikrobiolohichnyi Zhurnal 65: 39-45.
22. Sharipova, I.S., Sergevnin, V.I., Krasinski, W.L., Fediaeva, A.P., Neschisliaev, V.A. and Kravtsova, N.B., 1993. An evaluation of the therapeutic and prophylactic action of lactobacterin suppositories on the intestinal microbiocenosis in children. Zhurnal Mikrobiologii, Epidemiologii, i Immunobiologii 6: 30-31.
23. Spurbeck, R.R. and Arvidson, C.G., 2011. Lactobacilli at the front line of defense against vaginally acquired infections. Future Microbiology 6: 567-582.
24. Svetoch, E.A., Eruslanov, B.V., Levchuk, V.P., Perelygin, V.V., Mitsevich, E.V., Mitsevich, I.P., Stepanshin, J., Dyatlov, I., Seal, B.S. and Stern, N.J., 2011. Isolation of Lactobacillus salivarius 1077 (NRRL B-50053) and characterization of its bacteriocin, including the antimicrobial activity spectrum. Applied and Environmental Microbiology 77: 2749-2754.
25. Tallmeister, E.T., Lentsner, K.P. and Lentsmer, A.A., 1977. Effect of lactic acid bacteria metabolic products on the transmission of R-plasmids in enterobacteria in vitro. Zhurnal Mikrobiologii, Epidemiologii, i Immunobiologii 8: 69-73.
26. Todorov, S.D., Furtado, D.N., Saad, S.M., Tome, E. and Franco, B.D., 2011. Potential beneficial properties of bacteriocin-producing lactic acid bacteria isolated from smoked salmon. Journal of Applied Microbiology 110: 971-986.
27. Tsimmerman, I.S., Subbotina, L.V. and Neschisliaev, V.A., 2010. Microbial antagonism and rationale for the use of probiotics in combined therapy of Helicobacter pylori-related diseases. Klinicheskaya Medicina 88: 35-42.
28. Turovskiy, Y., Ludescher, R.D., Aroutcheva, A.A., Faro, S. and Chikindas, M.L., 2009. Lactocin 160, a bacteriocin produced by vaginal Lactobacillus rhamnosus, targets cytoplasmic membranes of the vaginal pathogen, Gardnerella vaginalis. Probiotics and Antimicrobial Proteins 1: 67-74.